<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Cosciens Biopharma Inc. — News on 6ix</title>
<link>https://6ix.com/company/cosciens-biopharma-inc</link>
<description>Latest news and press releases for Cosciens Biopharma Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 20 Apr 2026 12:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/cosciens-biopharma-inc" rel="self" type="application/rss+xml" />
<item>
<title>COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations</title>
<link>https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-provides-update-on-its-plan-to-suspend-us-public-company-reporting-obligations</link>
<guid isPermaLink="true">https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-provides-update-on-its-plan-to-suspend-us-public-company-reporting-obligations</guid>
<pubDate>Mon, 20 Apr 2026 12:00:00 GMT</pubDate>
<description>TORONTO, ONTARIO, April 20, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB:...</description>
</item>
<item>
<title>COSCIENS Comments on Unusual Market Activity</title>
<link>https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-comments-on-unusual-market-activity</link>
<guid isPermaLink="true">https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-comments-on-unusual-market-activity</guid>
<pubDate>Tue, 07 Apr 2026 21:10:00 GMT</pubDate>
<description>TORONTO, ONTARIO, April 07, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB:...</description>
</item>
<item>
<title>COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update</title>
<link>https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-corporate-update</link>
<guid isPermaLink="true">https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-corporate-update</guid>
<pubDate>Wed, 25 Mar 2026 21:05:00 GMT</pubDate>
<description>TORONTO, ONTARIO, March 25, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB:...</description>
</item>
<item>
<title>Upcoming Meeting Dates - March 23, 2026</title>
<link>https://6ix.com/company/cosciens-biopharma-inc/news/upcoming-meeting-dates-march-23-2026-44</link>
<guid isPermaLink="true">https://6ix.com/company/cosciens-biopharma-inc/news/upcoming-meeting-dates-march-23-2026-44</guid>
<pubDate>Mon, 23 Mar 2026 04:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - March 23, 2026) - The following is a list of Upcoming Meeting...</description>
</item>
<item>
<title>COSCIENS Provides Strategic Update</title>
<link>https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-provides-strategic-update-8</link>
<guid isPermaLink="true">https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-provides-strategic-update-8</guid>
<pubDate>Thu, 05 Mar 2026 22:10:00 GMT</pubDate>
<description>TORONTO, ONTARIO, March 05, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA:...</description>
</item>
<item>
<title>COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen&#xAE; in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore</title>
<link>https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-announces-exclusive-distribution-agreement-with-wuzhou-drug-international-for-macrilenandxae-in-hainan-guangdong-hong-kong-macao-greater-bay-area-and-singapore</link>
<guid isPermaLink="true">https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-announces-exclusive-distribution-agreement-with-wuzhou-drug-international-for-macrilenandxae-in-hainan-guangdong-hong-kong-macao-greater-bay-area-and-singapore</guid>
<pubDate>Mon, 01 Dec 2025 22:05:00 GMT</pubDate>
<description>TORONTO, ONTARIO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA:...</description>
</item>
<item>
<title>COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen® in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore</title>
<link>https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-announces-exclusive-distribution-agreement-220500820</link>
<guid isPermaLink="true">https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-announces-exclusive-distribution-agreement-220500820</guid>
<pubDate>Mon, 01 Dec 2025 22:05:00 GMT</pubDate>
<description>TORONTO, ONTARIO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“COSCIENS” or the “Company”), a life sciences company focused on pharmaceutical therapies, diagnostic products, and natural ingredients solutions, today announced that its wholly-owned subsidiary, Aeterna Zentaris GmbH, has entered into an exclusive distribution agreement with Wuzhou Drug International Trading Limited (“Wuzhou”) for the commercialization of Macrilen® (macimorelin) in Hong Kong</description>
</item>
<item>
<title>COSCIENS Biopharma Inc. Announces Leadership Change</title>
<link>https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-announces-leadership-change</link>
<guid isPermaLink="true">https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-announces-leadership-change</guid>
<pubDate>Fri, 14 Nov 2025 22:15:00 GMT</pubDate>
<description>TORONTO, ONTARIO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA:...</description>
</item>
<item>
<title>COSCIENS Biopharma Inc. Reports Third Quarter 2025 Financial Results and Provides Strategic Initiatives Update</title>
<link>https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-reports-third-quarter-2025-financial-results-and-provides-strategic-initiatives-update</link>
<guid isPermaLink="true">https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-reports-third-quarter-2025-financial-results-and-provides-strategic-initiatives-update</guid>
<pubDate>Tue, 11 Nov 2025 22:15:00 GMT</pubDate>
<description>COSCIENS voluntarily delists from Nasdaq, while retaining the Company&#x2019;s listing on the TSX...</description>
</item>
<item>
<title>COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update</title>
<link>https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-reports-second-quarter-2025-financial-results-and-provides-strategic-initiatives-update</link>
<guid isPermaLink="true">https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-reports-second-quarter-2025-financial-results-and-provides-strategic-initiatives-update</guid>
<pubDate>Thu, 14 Aug 2025 21:20:00 GMT</pubDate>
<description>COSCIENS Board of Directors approves a plan to voluntarily delist from Nasdaq , while retai...</description>
</item>
<item>
<title>COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders</title>
<link>https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-announces-results-of-virtual-2025-meeting-of-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-announces-results-of-virtual-2025-meeting-of-shareholders</guid>
<pubDate>Mon, 30 Jun 2025 22:33:00 GMT</pubDate>
<description>TORONTO, ONTARIO, June 30, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX:...</description>
</item>
<item>
<title>COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders</title>
<link>https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-reconstitutes-board-for-benefit-of-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-reconstitutes-board-for-benefit-of-shareholders</guid>
<pubDate>Fri, 30 May 2025 21:00:00 GMT</pubDate>
<description>Reconstituted Board to Revitalize COSCIENS TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- ...</description>
</item>
<item>
<title>COSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for the Upcoming Annual and Special Meeting of Shareholders</title>
<link>https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-acknowledges-receipt-of-intended-director-nominations-from-goodwood-for-the-upcoming-annual-and-special-meeting-of-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-acknowledges-receipt-of-intended-director-nominations-from-goodwood-for-the-upcoming-annual-and-special-meeting-of-shareholders</guid>
<pubDate>Mon, 26 May 2025 10:50:00 GMT</pubDate>
<description>TORONTO, ONTARIO, May 26, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX:...</description>
</item>
<item>
<title>Goodwood to Nominate New Directors for COSCIENS Biopharma Inc.</title>
<link>https://6ix.com/company/cosciens-biopharma-inc/news/goodwood-to-nominate-new-directors-for-cosciens-biopharma-inc</link>
<guid isPermaLink="true">https://6ix.com/company/cosciens-biopharma-inc/news/goodwood-to-nominate-new-directors-for-cosciens-biopharma-inc</guid>
<pubDate>Fri, 23 May 2025 20:30:00 GMT</pubDate>
<description>Goodwood to Nominate New Directors for COSCIENS Biopharma Inc. Canada NewsWire ...</description>
</item>
<item>
<title>COSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update</title>
<link>https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-reports-first-quarter-2025-financial-results-and-provides-a-corporate-update</link>
<guid isPermaLink="true">https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-reports-first-quarter-2025-financial-results-and-provides-a-corporate-update</guid>
<pubDate>Tue, 13 May 2025 21:05:00 GMT</pubDate>
<description>Repositioned as a pure-play natural-based product company following strategic review and pipeline...</description>
</item>
<item>
<title>COSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn as Chief Executive Officer</title>
<link>https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-appoints-global-consumer-products-and-biosciences-executive-anna-biehn-as-chief-executive-officer</link>
<guid isPermaLink="true">https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-appoints-global-consumer-products-and-biosciences-executive-anna-biehn-as-chief-executive-officer</guid>
<pubDate>Mon, 14 Apr 2025 11:00:00 GMT</pubDate>
<description>25+ years of experience in executive leadership roles and developing global strategic growth plan...</description>
</item>
<item>
<title>COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update</title>
<link>https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-reports-fourth-quarter-and-full-year-2024-financial-results-and-provides-a-corporate-update</link>
<guid isPermaLink="true">https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-reports-fourth-quarter-and-full-year-2024-financial-results-and-provides-a-corporate-update</guid>
<pubDate>Wed, 09 Apr 2025 21:00:00 GMT</pubDate>
<description>Fully repositioned as a pure-play natural-based product company following strategic review and pi...</description>
</item>
<item>
<title>COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order</title>
<link>https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-announces-receipt-of-management-cease-trade-order</link>
<guid isPermaLink="true">https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-announces-receipt-of-management-cease-trade-order</guid>
<pubDate>Tue, 01 Apr 2025 23:25:00 GMT</pubDate>
<description>TORONTO, ONTARIO, April 01, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TS...</description>
</item>
<item>
<title>COSCIENS Biopharma Inc. Announces Possible Delay in Filing Year-End Reporting Documents</title>
<link>https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-announces-possible-delay-in-filing-year-end-reporting-documents</link>
<guid isPermaLink="true">https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-announces-possible-delay-in-filing-year-end-reporting-documents</guid>
<pubDate>Wed, 19 Mar 2025 23:33:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - March 19, 2025) - COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX...</description>
</item>
<item>
<title>COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product</title>
<link>https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-announces-successful-phase-1-results-supporting-initiation-of-phase-2a-clinical-efficacy-trial-with-avenanthramides-as-a-potential-anti-inflammatory-product</link>
<guid isPermaLink="true">https://6ix.com/company/cosciens-biopharma-inc/news/cosciens-biopharma-inc-announces-successful-phase-1-results-supporting-initiation-of-phase-2a-clinical-efficacy-trial-with-avenanthramides-as-a-potential-anti-inflammatory-product</guid>
<pubDate>Thu, 13 Mar 2025 11:55:00 GMT</pubDate>
<description>No significant clinical adverse event observed in Phase 1clinical study Pharmacokinetic p...</description>
</item>
</channel>
</rss>